NewLink Genetics Names Jack Henneman CFO - Quick Facts

(RTTNews) - NewLink Genetics Corp (NLNK), a biopharmaceutical company, Wednesday named Jack Henneman as executive vice president and chief financial officer, effective immediately. Henneman replaces Gordon Link, Jr.

Henneman has more than 20 years of financial and operational management experience in the life sciences industry. Prior to joining NewLink, Henneman served Integra LifeSciences in various capacities for sixteen years, including as General Counsel and Chief Administrative Officer, and since 2007 as CFO.

NLNK closed Wednesday at $22.95, up $1.53 or 7.14%, on a volume of 1.6 million shares on the Nasdaq. In after hours, the stock dropped $1.95 or 8.50%.